Inhibition of complement pathway activation with Pozelimab, a fully human antibody to complement component C5

Toward complement inhibition 2.0: Next generation anticomplement agents for paroxysmal nocturnal hemoglobinuria

(2018) Antonio M. Risitano et al.   AMERICAN JOURNAL OF HEMATOLOGY

Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action

(2018) Douglas Sheridan et al.   PLoS One

Structural basis for therapeutic inhibition of complement C5

(2016) Matthijs M Jore et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Structural basis for therapeutic inhibition of complement C5

(2016) Matthijs M Jore et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin

(2015) Michal Pyzik et al.   JOURNAL OF IMMUNOLOGY

Calcium-dependent antigen binding as a novel modality for antibody recycling by endosomal antigen dissociation

(2015) N Hironiwa et al.   mAbs

Complement, a target for therapy in inflammatory and degenerative diseases

(2015) B. Paul Morgan et al.   NATURE REVIEWS DRUG DISCOVERY

Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection

(2015) Kristen E. Pascal et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome

(2015) Edwin K.S. Wong et al.   Translational Research

Enlarging the repertoire of therapeutic monoclonal antibodies platforms: domesticating half molecule exchange to produce stable IgG4 and IgG1 bispecific antibodies

(2014) Xiaoyu Yang et al.   CURRENT OPINION IN BIOTECHNOLOGY

Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice

(2014) A. J. Murphy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization

(2010) Tomoyuki Igawa et al.   NATURE BIOTECHNOLOGY

Complement component 5a (C5a)

(2009) Helga D. Manthey et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY